SCOPUS 정보 검색 플랫폼

Bone

Volumn 38, Issue 2 SUPPL., 2006, Pages 3-7

Pharmacological therapy of Paget's and other metabolic bone diseases

(1) Hosking, David a

a NOTTINGHAM CITY HOSPITAL (United Kingdom)

Author keywords

Bisphosphonate; Metabolic bone disease; Paget's disease; Zoledronic acid

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE; BISPHOSPHONIC ACID DERIVATIVE; PHOSPHATE; RISEDRONIC ACID; TILUDRONIC ACID; UNCLASSIFIED DRUG; ZOLEDRONIC ACID;

BONE STRUCTURE; BONE TURNOVER; CLINICAL TRIAL; DRUG DOSE REGIMEN; DRUG FATALITY; DRUG SAFETY; DRUG TOLERANCE; FLU LIKE SYNDROME; HUMAN; HYPOCALCEMIA; KIDNEY FAILURE; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PAGET BONE DISEASE; REVIEW;

EID: 31744441494 PISSN: 87563282 EISSN: None Source Type: Journal
DOI: 10.1016/j.bone.2005.11.011 Document Type: Article

Times cited : (23)

References (8)

1
- 0036062211
- Pharmacological profile of zoledronic acid: A highly potent inhibitor of bone resorption
- J.R. Green, and M.J. Rogers Pharmacological profile of zoledronic acid: a highly potent inhibitor of bone resorption Drug Dev. Res. 55 2002 210 224
- (2002) Drug Dev. Res. , vol.55 , pp. 210-224
- Green, J.R.¹ Rogers, M.J.²

2
- 0037103322
- Highly potent geminal bisphosphonates. from pamidronate disodium (Aredia) to zoledronic acid (Zometa)
- L. Widler, K.A. Jaeggi, M. Glatt, K. Muller, R. Bachmann, and M. Bisping Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa) J. Med. Chem. 45 2002 3721 3738
- (2002) J. Med. Chem. , vol.45 , pp. 3721-3738
- Widler, L.¹ Jaeggi, K.A.² Glatt, M.³ Muller, K.⁴ Bachmann, R.⁵ Bisping, M.⁶

3
- 0031059787
- The management of Paget's disease of bone
- P.D. Delmas, and P.J. Meunier The management of Paget's disease of bone N. Engl. J. Med. 336 1997 558 566
- (1997) N. Engl. J. Med. , vol.336 , pp. 558-566
- Delmas, P.D.¹ Meunier, P.J.²

4
- 0347816234
- 341)
- 341) J. Bone Miner. Res. 17 Suppl 1 2002 S368
- (2002) J. Bone Miner. Res. , vol.17 , Issue.1 SUPPL. , pp. 368
- Nancollas, G.H.¹ Tang, R.² Gulde, S.³ Ebetino, F.J.⁴ Phipps, R.J.⁵ Russell, R.G.G.⁶

5
- 24044431619
- Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease
- I.R. Reid, P. Miller, K. Lyles, W. Fraser, J.P. Brown, and Y. Saidi Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease N. Engl. J. Med. 353 2005 898 908
- (2005) N. Engl. J. Med. , vol.353 , pp. 898-908
- Reid, I.R.¹ Miller, P.² Lyles, K.³ Fraser, W.⁴ Brown, J.P.⁵ Saidi, Y.⁶

6
- 0027487284
- Determinants of remission of Paget's disease of bone
- S. Patel, M.D. Stone, C. Coupland, and D.J. Hosking Determinants of remission of Paget's disease of bone J. Bone Miner. Res. 8 1993 1467 1473
- (1993) J. Bone Miner. Res. , vol.8 , pp. 1467-1473
- Patel, S.¹ Stone, M.D.² Coupland, C.³ Hosking, D.J.⁴

7
- 0030227986
- Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones
- P. Masarachia, M. Weinreb, R. Balena, and G.A. Rodan Comparison of the distribution of 3H-alendronate and 3H-etidronate in rat and mouse bones Bone 19 1996 281 290
- (1996) Bone , vol.19 , pp. 281-290
- Masarachia, P.¹ Weinreb, M.² Balena, R.³ Rodan, G.A.⁴

8
- 10544223736
- Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: A randomized, placebo-controlled trial
- I.R. Reid, G.C. Nicholson, R.S. Weinstein, D.J. Hosking, T. Cundy, and M.A. Kotowicz Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial [erratum appears in Am J Med 1997;102:322] Am. J. Med. 101 1996 341 348
- (1996) Am. J. Med. , vol.101 , pp. 341-348
- Reid, I.R.¹ Nicholson, G.C.² Weinstein, R.S.³ Hosking, D.J.⁴ Cundy, T.⁵ Kotowicz, M.A.⁶

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.